Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128000801 | 12800080 | 1 | I | 20150408 | 20160920 | 20160930 | 20160930 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK138714 | GLAXOSMITHKLINE | MA W, LEI Y. PHARMACEUTICAL PRACTICE FOR PATIENT WITH ACUTE-ON-CHRONIC LIVER FAILURE BY CLINICAL PHARMACISTS. EVALUATION AND ANALYSIS OF DRUG-USE IN HOSPITALS OF CHINA. 2016;16 (5):699-700 | 42.00 | YR | M | Y | 0.00000 | 20160930 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128000801 | 12800080 | 1 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Oral | 100 MG, QD | 21003 | 100 | MG | QD | |||||||
| 128000801 | 12800080 | 2 | C | THYMOSIN | THYMOSIN | 1 | 15 MG, QD | 0 | 15 | MG | QD | ||||||||
| 128000801 | 12800080 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 50 MG, BID | 0 | 50 | MG | BID | ||||||||
| 128000801 | 12800080 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 128000801 | 12800080 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 40 MG, BID | 0 | 40 | MG | BID | ||||||||
| 128000801 | 12800080 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 128000801 | 12800080 | 1 | Hepatitis B |
| 128000801 | 12800080 | 2 | Product used for unknown indication |
| 128000801 | 12800080 | 3 | Abdominal distension |
| 128000801 | 12800080 | 4 | Oedema peripheral |
| 128000801 | 12800080 | 5 | Abdominal distension |
| 128000801 | 12800080 | 6 | Oedema peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 128000801 | 12800080 | OT |
| 128000801 | 12800080 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 128000801 | 12800080 | Abdominal distension | |
| 128000801 | 12800080 | Asthenia | |
| 128000801 | 12800080 | Condition aggravated | |
| 128000801 | 12800080 | Decreased appetite | |
| 128000801 | 12800080 | Drug resistance | |
| 128000801 | 12800080 | Hepatic failure | |
| 128000801 | 12800080 | Jaundice | |
| 128000801 | 12800080 | Liver disorder | |
| 128000801 | 12800080 | Nausea | |
| 128000801 | 12800080 | Pathogen resistance | |
| 128000801 | 12800080 | Scleral disorder | |
| 128000801 | 12800080 | Skin haemorrhage | |
| 128000801 | 12800080 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |